Table 2.
Classification | Target |
---|---|
Oral toxicity | LD50, toxicity class |
Organ toxicity | Hepatotoxicity |
Toxicity end points | Carcinogenicity, immunotoxicity, mutagenicity, and cytotoxicity |
Tox21-nuclear receptor signalling pathways | Aryl hydrocarbon receptor (AhR), androgen receptor (AR), androgen receptor ligand binding domain (AR-LBD), aromatase, estrogen receptor alpha (ER), estrogen receptor ligand binding domain (ER-LBD), and peroxisome proliferator-activated receptor gamma (PPAR-gamma) |
Tox21-stress response pathways | Nuclear factor (erythroid-derived 2)-like 2/antioxidant responsive element (nrf2/ARE), heat shock factor response element (HSE), mitochondrial membrane potential (MMP), phosphoprotein (tumor suppressor) p53, and ATPase family AAA domain-containing protein 5 (ATAD5) |
LD50, median lethal dose; Tox21, toxicology in the 21st century (a unique collaboration between several US federal agencies to develop new ways to rapidly test whether substances adversely affect human health).